No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Here's Why Sandoz Group AG Sponsored ADR (SDZNY) Is a Great 'Buy the Bottom' Stock Now
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Sandoz Gains European Commission Approval For Afqlir (Aflibercept), Targeting Wider Access Biosimilars In Europe
FDA Accepts Organon BLA for Prolia/Xgeva Biosimilar
Sandoz Raised Its 2024 Net Sales Growth Guidance To High-Single Digits In Constant Currency; Maintains Core EBITDA Margin Guidance At ~20%
Sandoz US Launches Generic Paclitaxel in Single-dose Vial, Further Expanding US Oncology Portfolio